Two years of low density lipoprotein apheresis in familial hypercholesterolemia: Effects on cholesterol metabolism and coronary artery disease

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 8, Issue 3, 1998, Pages 164-171

  Gylling, H ^a   Virtanen, K S ^a   Syvanne M ^a   Miettinen, T A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cholesterol absorption and synthesis; Familial hypercholesterolemia; Lathosterol; LDL apheresis; Squalene

Indexed keywords

EID: 0013009422     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Thompson GR, Lowenthal R, Myant NB (1975) Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet i: 1208-1211
2. Thompson GR, Myant NB, Kilpatrick D, Oakley CM, Raphael MJ, Steiner RE (1980) Assessment of long-term plasma exchange for familial hypercholesterolaemia. Br Heart J 43: 680-688
3. Yokoyama S, Hayashi R, Satani M, Yamamoto A (1985) Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 5: 613-622
4. Saal SD, Parker TS, Gordon BR, Studebaker J, Hudgins L, Ahrens EH Jr, Rubin AL (1986) Removal of low-density lipoproteins in patients by extracorporeal immunoadsorption. Am J Med 80: 583-589
5. Levy RA, Ostlund RE Jr, Goldberg AC, Grundy SM (1986) Long-term changes in cholesterol biosynthesis and the effect of plasmapheresis therapy in a hypercholesterolemic homozygote. Metabolism 35: 415-418
6. Eisenhauer T, Armstrong VW, Wieland H, Fuchs C, Scheler F, Seidel D (1987) Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system. Klin Wochenschr 65: 161-168
7. Seidel D, Armstrong VW, Schuff-Werner P, for the HELP Study Group (1991) The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. Eur J Clin Invest 21: 375-383
8. Franceschini G, Busnach G, Calabresi L, Chiesa G, Gianfranceschi G, Zoppi F et al (1991) Predictability of low-density lipoprotein levels during apheretic treatment of hypercholesterolaemia. Eur J Clin Invest 21: 209-214
9. Parker TS (1991) Low-density lipoprotein apheresis selective removal of apolipoprotein B-containing lipoproteins in patients with familial hypercholesterolemia. In: Gordon BR, Gotto AM Jr (eds). The treatment of severe hypercholesterolemia: can we impact disease course? Proceedings of a symposium November 9, 1991, Anaheim, Ca. Princeton, NJ. Excerpta Medica, Inc. Elsevier Company, pp. 31-42
10. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y et al (1992) Regression of coronary artherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 95: 1-13
11. Richter WO, Jacob BG, Ritter MM, Suhler K, Vierneisel K, Schwandt P (1993) Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism 42: 888-894
12. Pfohl M, Naoumova RP, Klass C, Knisel W, Jakober B, Risler T, Thompson GR (1994) Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy. J Lipid Res 35: 1946-1955
13. Thompson GR, Miller JP, Breslow JL (1985) Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange. Br Med J 291: 1671-1673
14. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R et al (1987) A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 68: 19-25
15. Thompson GR, Myant NB (1976) Low density lipoprotein turnover in familial hypercholesterolaemia after plasma exchange. Atherosclerosis 23: 371-377
16. Soutar AK, Myant NB, Thompson GR (1979) Metabolism of apolipoprotein B-containing lipoproteins in familial hypercholesterolaemia. Atherosclerosis 32: 315-325
17. Simons LA, Gibson JC, Isbister JP, Biggs JC (1978) The effects of plasma exchange on cholesterol metabolism. Atherosclerosis 31: 195-204
18. Miettinen TA (1982) Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. J Lipid Res 23: 466-473
19. Parker TS, McNamara DJ, Brown CD, Kolb R, Ahrens EH Jr, Alberts AW et al (1984) Plasma mevalonate as a measure of cholesterol biosynthesis in man. J Clin Invest 74: 795-804
20. Aalto-Setälä K, Koivisto U-M, Miettinen TA, Gylling H, Kesäniemi YA, Savolainen M et al (1992) Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland. J Int Med 231: 227-234
21. Warnick GR, Albers JJ (1978) A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19: 65-76
22. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502
23. Miettinen TA, Koivisto P (1983) Non-cholesterol sterols and bile acid production in hypercholesterolaemic patients with ileal bypass. In: Paumgartner G, Stiehl A, Gerok W (eds) Bile acids and cholesterol in health and disease. MTP Press, Boston, pp. 183-187
24. Crouse JR, Grundy SM (1978) Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man. J Lipid Res 19: 967-971
25. 3) when used as an index substance. Science 116: 634-635
26. Miettinen TA (1982) Gas-liquid Chromatographic determination of fecal neutral sterols using a capillary column. Clin Chim Acta 124: 245-248
27. Miettinen TA, Ahrens EH Jr, Grundy SM (1965) Quantitative isolation and gas-liquid Chromatographic analysis of total dietary and fecal neutral steroids. J Lipid Res 6: 411-424
28. Grundy SM, Ahrens EH Jr, Miettinen TA (1965) Quantitative isolation and gas-liquid Chromatographic analysis of total fecal bile acids. J Lipid Res 6: 397-410
29. Syvänne M, Nieminen MS, Frick MH (1994) Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery: a validation study. Int J Vascular Imaging 10: 243-252
30. De Feyter PJ, Serruys PW, Davies MJ, Richardson P, Lubsen J, Oliver MF (1991) Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis: value, limitations, and implications for clinical trials. Circulation 84: 412-423
31. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ et al (1985) Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 71: 280-288
32. Kupari M, Virtanen KS, Turto H, Viitasalo M, Mänttäri M, Lindroos M et al (1992) Exclusion of coronary artery disease by exercise thallium-201 tomography in patients with aortic valve stenosis. Am J Cardiol 70: 635-640
33. Schuff-Werner P, Gohlke H, Bartmann U, Baggio G, Corti MC, Dinsenbacher A et al (1994) The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. Eur J Clin Invest 24: 724-732
34. Kitabatake A, Sato H, Hori M, Kamada T, Kubori S, Hoki N et al (1994) Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. Clin Ther 16: 416-428
35. Aengevaeren WRM, Kroon AA, Stalenhoef AFH, Uijen GJH, Van der Werf T (1996) Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hyperc-holesterolaemia and extensive coronary artery disease. The LDL-Apheresis Atherosclerosis Regression Study (LAARS). J Am Coll Cardiol 28: 1696-1704
36. Thompson GR, Maher VMG, Matthews S, Kitano Y, Neuwirth C, Shortt MB et al (1995) Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet 345: 811-816
37. Kroon AA, Aengevaeren WRM, Van der Werf T, Uijen GJH, Reiber JHC, Bruschke AVG, Stalenhoef AFH (1996) LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 93: 1826-1835
38. Saudek CD, Frier BM, Liu GCK (1978) Plasma squalene: lipoprotein distribution and kinetic analysis. J Lipid Res 19: 827-835
39. Liu GCK, Ahrens EH Jr, Schreibman PH, Samuel P, McNamara DJ, Crouse JR (1975) Measurement of cholesterol synthesis in man by isotope kinetics of squalene. Proc Natl Acad Sci USA 72: 4612-4616
40. Miettinen TA, Kesäniemi YA (1989) Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr 49: 629-635
41. Gylling H, Miettinen TA (1994) Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37: 773-780